Progression-free survival - Wikipedia
Progression-free survival (PFS) is "the length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but it does not get worse".[1] In oncology, PFS usually refers to situations in which a tumor is present, as demonstrated by laboratory testing, radiologic testing, or clinically. Similarly, "disease-free survival" is the length of time after patients have received treatment and have no detectable disease. Time to progression (TTP) does not count patients who die from other causes but is otherwise a close equivalent to PFS (unless there are many such events).[2] The FDA gives separate definitions and prefers PFS.[3] PFS is widely used as a surrogate endpoint in oncology.[4] The definition of "progression" generally involves imaging techniques (plain radiograms, CT scans, MRI, PET scans, ultrasounds) or other aspects: biochemical progression may be defined on the basis of an increase in a tumor marker (such as CA125 for epithelial ovar
Progression-free survival - Wikipedia Jump to content From Wikipedia, the free encyclopedia Time living with a disease that does not get worse Progression-free survival ( PFS ) is "the length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but it does not get worse". [ 1 ] In oncology , PFS usually refers to situations in which a tumor is present, as demonstrated by laboratory testing, radiologic testing, or clinically. Similarly, "disease-free survival" is the length of time after patients have received treatment and have no detectabl
Explore this link on the map →related reading
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- On the Value of Advancing Progress - Toby Ordtobyord.com
- Pancreatic Cancer - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
- Has pancreatic cancer met its match?worksinprogress.co
- On the Value of Advancing Progress — EA Forumforum.effectivealtruism.org
- Systemic Bottlenecks & Misalignmentscurecancer.ai
- UpToDateuptodate.com
- OLIGOMA Trial: SBRT Extends PFS in Oligometastatic Breast Cancer - OncoDailyoncodaily.com
- Unmet Needs Index — Biopharma Disease Prioritizationinsights.convoke.bio
- Checking your browser - reCAPTCHApmc.ncbi.nlm.nih.gov
- 醫學統計學bookdown.org
- US cancer death rate drops 33% since 1991, partly due to advances in treatment, early detection and less smoking, new report says | CNNedition.cnn.com